Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial

    Nan Bi (毕宁)
    Nan Bi (毕宁)
    [0]
    Lipin Liu
    Lipin Liu
    [0]
    Jun Liang
    Jun Liang
    [0]
    Shixiu Wu
    Shixiu Wu
    Ming Chen
    Ming Chen
    [0]
    Changxing Lv
    Changxing Lv
    Lujun Zhao (赵路军)
    Lujun Zhao (赵路军)
    [0]
    Anhui Shi
    Anhui Shi
    Wei Jiang
    Wei Jiang
    Yaping Xu
    Yaping Xu
    Zongmei Zhou
    Zongmei Zhou
    [0]
    Jingbo Wang
    Jingbo Wang
    More

    BMC cancer, pp. 2782020.

    Cited by: 0|Bibtex|Views12|Links
    WOS
    Keywords:
    ChemoradiotherapyECOG 2EfficacyLocally advancedNon-small-cell lung cancerMore(1+)

    Abstract:

    ClinicalTrials.gov registration number: NCT01494558. (Registered 19 December 2011).

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments